MAIA Biotechnology Files 8-K for Bylaw Amendments

Ticker: MAIA · Form: 8-K · Filed: May 23, 2025 · CIK: 1878313

Sentiment: neutral

Topics: corporate-governance, filing

TL;DR

MAIA Bio filed an 8-K for bylaw changes and exhibits. No major financial news.

AI Summary

MAIA Biotechnology, Inc. filed an 8-K on May 23, 2025, reporting events as of May 22, 2025. The filing primarily concerns amendments to its articles of incorporation or bylaws and includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Chicago, IL.

Why It Matters

This filing indicates potential changes in MAIA Biotechnology's corporate governance or operational structure, which could impact its strategic direction and shareholder rights.

Risk Assessment

Risk Level: low — The filing is procedural, detailing corporate governance updates and exhibit submissions, without disclosing significant financial events or material changes.

Key Players & Entities

FAQ

What specific amendments were made to MAIA Biotechnology's articles of incorporation or bylaws?

The filing indicates that amendments were made, but the specific details of these amendments are not provided in the provided text, which focuses on the form type and filing information.

What financial statements and exhibits are included with this 8-K filing?

The filing states that 'Financial Statements and Exhibits' are included, but the specific content of these documents is not detailed in the provided excerpt.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on May 22, 2025.

What is MAIA Biotechnology, Inc.'s principal executive office address?

MAIA Biotechnology, Inc.'s principal executive office is located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.

What is MAIA Biotechnology, Inc.'s telephone number?

MAIA Biotechnology, Inc.'s telephone number is (312) 416-8592.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 23, 2025 regarding MAIA Biotechnology, Inc. (MAIA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing